078140 — Daebongls Co Income Statement

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeSmall CapNeutral

Annual income statement for Daebongls Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	Annual Audited Accounts	Annual Audited Accounts	ARS	ARS	Annual Audited Accounts
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	76,255	82,957	93,504	87,622	93,954
Cost of Revenue
Gross Profit	20,671	23,576	24,959	21,445	26,795
Selling / General / Administrative Expenses
Research And Development
Depreciation and Amortization
Total Operating Expenses	68,133	73,272	85,330	83,821	84,900
Operating Profit	8,122	9,686	8,174	3,801	9,054
Gain / Loss on Sale of Assets
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	8,679	12,195	10,713	6,305	11,166
Provision for Income Taxes
Net Income After Taxes	7,395	10,042	11,794	6,182	9,687
Minority Interest
Net Income Before Extraordinary Items
Net Income	5,821	6,789	8,628	4,182	7,339
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	5,821	6,789	8,628	4,182	7,339
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	526	619	787	383	671
Dividends per Share